DrugDashboards

Vistogard

uridine triacetate · URIDINE TRIACETATE 951 mg/g · Granule · Oral · BTG International Inc

NDC 50633-0220-04 · 4 PACKET in 1 CARTON / 10 g in 1 PACKET · NDA · View full market →

The short version

Only one company currently supplies this market — there is no backup if it stumbles.

The numbers behind every sentence are on this page below — and the Watch button emails you when any of them move.

Medicare Part D

No Medicare Part D plan in CMS's quarterly files lists this product. That usually means it is discontinued, a repackager's listing, or a product no plan has added to its formulary.

How Part D pricing works →

NADAC price per unit

No NADAC pricing on file for this NDC — NADAC covers drugs dispensed by retail community pharmacies.

Estimated fill cost

WAC per package, as filed
$18,584.00
Reported to Texas DSHS · 2026 annual filing · BTG International Inc.

Manufacturer list price as filed — not what pharmacies actually pay after discounts.

Supply fragility

Not scored — fragility is computed for NADAC-priced NDCs.

Where it's made

Establishments this product's FDA label declares, located via FDA registration data. How we built this →

Regulatory

Application
NDA208159
TE code
Approval date
Dec 11, 2015
Patents / exclusivity
1 patents, 0 exclusivities
TypeNumber / codeExpires
patent7776838Aug 17, 2027

Shortage history

No FDA shortage reports for this drug or its presentations.

Recalls (this NDC)

No enforcement reports list this package NDC.

Manufacturers of uridine triacetate (Granule)

LabelerStrengthFirst seenLast seen
BTG International IncURIDINE TRIACETATE 951 mg/gJul 15, 2026Sep 3, 2026

Roster from daily NDC Directory diffs — first/last seen dates start July 2026.

Cite this page

DrugDashboards, "Vistogard — NDC 50633-0220-04," retrieved September 3, 2026, https://drugdashboards.com/drug/50633022004.

Free to cite with attribution — see how the data is put together.